Department of Surgery, University of Chicago, 5841 S Maryland Ave, Chicago, IL, 60637, USA.
Surg Endosc. 2019 Jul;33(7):2181-2186. doi: 10.1007/s00464-018-6497-1. Epub 2018 Oct 26.
Cardiac left ventricular assist device (LVAD) placement is a common therapy for heart failure. Non-cardiac surgical care of these patients can be complex given the need for anticoagulation, perioperative monitoring, comorbidities, and anatomical considerations due to the device itself. There are no guidelines or significant patient series reported to date for laparoscopic procedures in this population. We herein report the techniques and outcomes for commonly performed laparoscopic procedures in patients with LVADs at a high volume center.
From our database of patients with ventricular assist devices, we retrospectively identified patients who underwent laparoscopic abdominal surgery. Intraoperative and perioperative data were collected, including anticoagulation management, transfusions and complications. Techniques and preoperative considerations from the surgeons were also compiled and described.
Of 374 patients that had placement of LVADs, 17 had an elective laparoscopic procedure: enteral access placement (n = 7), cholecystectomy (n = 6), hernia repair (n = 2), small bowel resection (n = 1) and splenectomy (n = 1). Preoperative evaluation routinely included radiologic imaging to evaluate driveline location. The most common abdominal entry technique was a periumbilical open Hasson technique (11/17). No cases were converted to open. Overall, the average blood loss was 132 ± 64 mL and the average operative time was 1.8 ± 0.3 h. Five of the 17 patients required intraoperative blood transfusion. No patients suffered perioperative thrombotic events or LVAD complications secondary to holding anticoagulation. No patients required interventions or reoperation for bleeding complications. There were no mortalities related to these procedures.
Laparoscopic abdominal procedures are safe and feasible in patients with LVADs. Although special consideration for bleeding and thrombotic risks, placement of ports and perioperative management is required, the presence of a LVAD itself should not be considered a contraindication for laparoscopic surgery and may in fact be the preferred method for access in these patients.
心脏左心室辅助装置(LVAD)的植入是心力衰竭的常见治疗方法。由于需要抗凝、围手术期监测、合并症以及由于装置本身引起的解剖学考虑,这些患者的非心脏外科护理可能很复杂。迄今为止,尚无针对该人群腹腔镜手术的指南或重要患者系列报告。在此,我们报告了在一家高容量中心,LVAD 患者中常见的腹腔镜手术的技术和结果。
从我们的心室辅助装置患者数据库中,我们回顾性地确定了接受腹腔镜腹部手术的患者。收集了术中及围手术期数据,包括抗凝管理、输血和并发症。还汇编并描述了外科医生的技术和术前考虑因素。
在 374 名植入 LVAD 的患者中,有 17 名患者接受了择期腹腔镜手术:肠内通道放置(n=7)、胆囊切除术(n=6)、疝修补术(n=2)、小肠切除术(n=1)和脾切除术(n=1)。术前评估通常包括影像学检查以评估驱动线位置。最常见的腹部进入技术是脐周开放式 Hasson 技术(17 例中的 11 例)。没有病例转为开放性手术。总的来说,平均失血量为 132±64ml,平均手术时间为 1.8±0.3 小时。17 例患者中有 5 例需要术中输血。没有患者因抗凝而发生围手术期血栓事件或 LVAD 并发症。没有患者因出血并发症需要干预或再次手术。这些手术没有导致死亡。
LVAD 患者的腹腔镜腹部手术是安全可行的。尽管需要特别注意出血和血栓形成风险、端口放置和围手术期管理,但LVAD 本身不应被视为腹腔镜手术的禁忌症,事实上,对于这些患者,腹腔镜手术可能是首选的入路方法。